Blavatnik Biomedical Accelerator

FUSION: A unique event for innovative leaders

Harvard’s FUSION symposium integrates perspectives from science and business to explore the promise of an emerging field. This annual, invite-only event brings together entrepreneurs, scientists, business leaders, investors, and innovators for a half-day of exploration and networking. The FUSION symposium is jointly hosted by the Blavatnik Biomedical Accelerator (a program of Harvard University's Office of Technology Development) and by the Blavatnik Fellowship in Life Science Entrepreneurship at Harvard Business School.

The fourth FUSION symposium will address The Science and Business of Cell and Gene Therapy. For more information, contact .(JavaScript must be enabled to view this email address).

FUSION 2019: The Science and Business of Aging

FUSION 2019 Recap

While the medical, scientific, and economic challenges related to aging are immense, many scientific and business leaders are engaged and are focused on practical, scalable, innovative solutions. Some solutions already exist, and others aren’t far off. Read the FUSION 2019 Summary

Professor of Medicine and of Genetics, Albert Einstein College of Medicine; Director of the Institute for Aging Research, Director of the Paul F. Glenn Center for the Biology of Human Aging Research, and Director of the NIH Nathan Shock Centers of Excellence in the Basic Biology of Aging

Global population aging is one of the greatest public health challenges of our time. Aging populations will affect the workforce. They will affect families and education and healthcare policies. They will strain healthcare systems, especially those in low-income communities and countries.

Michelle Williams

Dean, Harvard T.H. Chan School of Public Health

Lending insights to action for the aging world

The inevitable infirmities of aging may not be so certain after all. Though few products on the market today can help turn back the hands of time, that may soon change.